St John of God Murdoch Hospital is a 511-bed private non-profit hospital located in the southern suburbs of Perth in Western Australia, immediately adjacent to the public Fiona Stanley Hospital campus. The distance between the entrances to the emergency departments of these two hospitals is approximately 390 m.

There are 511 beds in St John of God Murdoch Hospital.

During the past decade, St John of God Murdoch Hospital conducted 21 clinical trials. In the 10-year time frame, 21 clinical trials started and 6 clinical trials were completed, i.e. on average, 28.6% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 5 clinical trials were completed. i.e. 71.4% of trials that started reached the finish line.

Out of the total clinical trials conducted in "St John of God Murdoch Hospital" #1 sponsor was "Australian and New Zealand Intensive Care Research Centre" with 3 trials, followed by "Janssen Research & Development, LLC" with 3 trials sponsored, "Amgen" with 2 trials sponsored, "DePuy Orthopaedics" with 2 trials sponsored and "Pfizer" with 2 trials sponsored. Other sponsors include 7 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "St John of God Murdoch Hospital" #1 collaborator was "Australian and New Zealand Intensive Care Society Clinical Trials Group" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator, "Australian Red Cross" with 1 trials as a collaborator, "Baxter Healthcare Corporation" with 1 trials as a collaborator and "Celgene Corporation" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "St John of God Murdoch Hospital" are "Gastric Cancer" (2 trials), "Pancreatic Cancer" (2 trials), "Advanced or Metastatic Non-small Cell Lung Cancer" (1 trials), "Age of Blood" (1 trials) and "Cancer of the Stomach" (1 trials). Many other conditions were trialed in "St John of God Murdoch Hospital" in a lesser frequency.

Most popular intervention types in "St John of God Murdoch Hospital" are "Drug" (16 trials), "Device" (7 trials), "Biological" (4 trials), "Other" (4 trials) and "Dietary Supplement" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (4 trials), "Lazertinib" (3 trials), "Amivantamab" (2 trials), "Bemarituzumab" (2 trials) and "FOLFOX" (2 trials). Other intervention names were less common.

The vast majority of trials in "St John of God Murdoch Hospital" are 24 trials for "All" genders.

Currently, there are NaN active trials in "St John of God Murdoch Hospital". undefined are not yet recruiting, 10 are recruiting, 7 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 7 completed trials in St John of God Murdoch Hospital, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in St John of God Murdoch Hospital, 2 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 14 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 4 trials that are defined as “Not Applicable".